vrchivadv014-00-vp
Vaccineexperimental
Clinical trial activity
15 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 18, 2004 (NCT00083330)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vrc-hivadv014-00
- vrc-hivadv014-00-vp
- vrchivadv014-00-vp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00955006 | Phase 1 | May 1, 2011 | National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
| NCT00709605 | Phase 1 | Jun 25, 2008 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00498056 | Phase 2 | Jul 5, 2007 | Centers for Disease Control and Prevention (CDC), Columbia University, HIV Vaccine Trials Network, International AIDS Vaccine Initiative, National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT01549509 | Phase 1 | Apr 1, 2007 | Makerere University, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00384787 | Phase 1 | Nov 1, 2006 | Asociación Civil Impacta Salud y Educación, Peru, HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), New York Blood Center |
| NCT00123968 | Phase 1/Phase 2 (Phase 2) | May 1, 2006 | Department of Defense, National Institute of Allergy and Infectious Diseases (NIAID), United States Army |
| NCT00321061 | Phase 1 | Apr 25, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00270218 | Phase 1 | Feb 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID), University of Washington, Vanderbilt University |
| NCT00125970 | Phase 2 | Sep 1, 2005 | Aurum Health Research Limited, National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00119873 | Phase 1 | Jul 12, 2005 | City of San Francisco, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00109629 | Phase 1 | Apr 26, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00108654 | Phase 1 | Apr 13, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00102089 | Phase 1 | Jan 18, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00091416 | Phase 1 | Sep 8, 2004 | National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco, University of Washington |
| NCT00083330 | Phase 1 | May 18, 2004 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 15 | 15 | 2 | 2004 |
| University of Washington | Academic/Hospital | 3 | 0 | 1 | 2004 |
| HIV Vaccine Trials Network | Academic/Hospital | 2 | 0 | 2 | 2006 |
| United States Army | Government | 2 | 0 | 1 | 2006 |
| Asociación Civil Impacta Salud y Educación, Peru | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Aurum Health Research Limited | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2007 |
| City of San Francisco | Government | 1 | 0 | 1 | 2005 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Department of Defense | Government | 1 | 0 | 1 | 2006 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Makerere University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| New York Blood Center | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2006 |
16 organizations
Page 1 / 1